GSK3B and Alzheimer disease: There is good evidence that GSK-3β-dependent phosphorylation of tau at serine 396 (Ser396) is significantly elevated in AD and that phosphorylation at the tau Ser396 site is crucial for the aberrant movement of tau to synapses [58].